chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Lung opacity, Malnutrition, Oesophagitis, Oral candidiasis, Peripheral arterial occlusive disease
Clinical narrative: Clinical Summary A 73 y.o. female with a history of ILD on chronic steroids, Sjogren's syndrome, iatrogenic Cushing's disease, anxiety and depression who presented to hospital 10/5/2022 with dyspnea and hypoxia SAT level 79% RA, CTPA showed multilobar ground glass opacities consistent with inflammatory or infectious process. COVID-19 negative initially then repeat 10/08/22 positive. Patient received empiric antibiotics, IV steroids, and Remdesivir with minimal improvement in hypoxia. She developed severe esophagitis with poor PO intake on chronic malnutrition. She also experienced acute RLE limb ischemia. Pulmonology, GI, peripheral cardiology, and palliative care followed. She was eventual changed to a DNRCC and was discharged.   1. Acute on chronic hypoxic respiratory failure: Suspect ILD exacerbation, complicated by COVID-19 infection, less likely bacterial process. CTPA showed multilobar ground glass opacities consistent with inflammatory or infectious process, RA sat 79%. Worsened clinically 10/07/22 and progressed from NC to HHF. Completed 5 day course of empiric Rocephin/Azithromycin 10/10/22. S/p IV solumedrol, switched to PO prednisone 10/12/22. Failed attempt at nasal oxymizer 10/12/22, successful on second attempt 10/14/22. Transitioned to DNRCC 10/15/22 given additional co-morbidities below. Symptom management per hospice. 2. Esophagitis: Concern for candida esophagitis given thrush and high dose steroids, possibly erosive given high dose steroids. GI consulted, recommended IV PPI BID and IV Pepcid. Symptom management per hospice. 3. Acute RLE limb ischemia: Patient noted pain and discoloration of RLE toes. ABIs with severe PAD. Peripheral cardiology evaluated, suspected embolic, poor candidate for intervention. Symptom management per hospice. 4. Hypercalcemia: Secondary to TUMS use. Initiated TUMS for above, patient/family requesting more, discussed risks of hypercalcemia. Notified that husband was also giving TUMS from home. Discontinued TUMS order and re-educated patient/husband. iCal improved with IVF. No further lab draws given goals of care. 5. COVID-19 pneumonia: COVID-19 initially negative but repeat 10/07/22 positive. Steroids as above. Completed Remdesivir 10/12/22. Pulmonology followed. 6. ILD: diagnosed 2019, follows with Dr. has been on chronic Prednisone 10 mg daily, was started on Dapson for prophylaxis 2020 but not taking now. Continued high dose steroids per pulmonology.  7. Sjogren's syndrome: mild, no specific organ involvement.  8. Anxiety and depression: continued home meds.  9. Thrush: Oral nystatin started 10/10/2022  10. Underweight/Severe malnutrition present on admission: BMI 16.19, patient denies anorexia. PO diet as tolerated, doesn't like any of the available protein supplements. Dietician followed. Patient and family decline artificial nutrition given goals of care.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral ischaemia, Respiratory failure, SARS-CoV-2 test positive, Skin discolouration, Underweight
Clinical narrative: Clinical Summary A 73 y.o. female with a history of ILD on chronic steroids, Sjogren's syndrome, iatrogenic Cushing's disease, anxiety and depression who presented to hospital 10/5/2022 with dyspnea and hypoxia SAT level 79% RA, CTPA showed multilobar ground glass opacities consistent with inflammatory or infectious process. COVID-19 negative initially then repeat 10/08/22 positive. Patient received empiric antibiotics, IV steroids, and Remdesivir with minimal improvement in hypoxia. She developed severe esophagitis with poor PO intake on chronic malnutrition. She also experienced acute RLE limb ischemia. Pulmonology, GI, peripheral cardiology, and palliative care followed. She was eventual changed to a DNRCC and was discharged.   1. Acute on chronic hypoxic respiratory failure: Suspect ILD exacerbation, complicated by COVID-19 infection, less likely bacterial process. CTPA showed multilobar ground glass opacities consistent with inflammatory or infectious process, RA sat 79%. Worsened clinically 10/07/22 and progressed from NC to HHF. Completed 5 day course of empiric Rocephin/Azithromycin 10/10/22. S/p IV solumedrol, switched to PO prednisone 10/12/22. Failed attempt at nasal oxymizer 10/12/22, successful on second attempt 10/14/22. Transitioned to DNRCC 10/15/22 given additional co-morbidities below. Symptom management per hospice. 2. Esophagitis: Concern for candida esophagitis given thrush and high dose steroids, possibly erosive given high dose steroids. GI consulted, recommended IV PPI BID and IV Pepcid. Symptom management per hospice. 3. Acute RLE limb ischemia: Patient noted pain and discoloration of RLE toes. ABIs with severe PAD. Peripheral cardiology evaluated, suspected embolic, poor candidate for intervention. Symptom management per hospice. 4. Hypercalcemia: Secondary to TUMS use. Initiated TUMS for above, patient/family requesting more, discussed risks of hypercalcemia. Notified that husband was also giving TUMS from home. Discontinued TUMS order and re-educated patient/husband. iCal improved with IVF. No further lab draws given goals of care. 5. COVID-19 pneumonia: COVID-19 initially negative but repeat 10/07/22 positive. Steroids as above. Completed Remdesivir 10/12/22. Pulmonology followed. 6. ILD: diagnosed 2019, follows with Dr. has been on chronic Prednisone 10 mg daily, was started on Dapson for prophylaxis 2020 but not taking now. Continued high dose steroids per pulmonology.  7. Sjogren's syndrome: mild, no specific organ involvement.  8. Anxiety and depression: continued home meds.  9. Thrush: Oral nystatin started 10/10/2022  10. Underweight/Severe malnutrition present on admission: BMI 16.19, patient denies anorexia. PO diet as tolerated, doesn't like any of the available protein supplements. Dietician followed. Patient and family decline artificial nutrition given goals of care.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Anaemia, Blood creatinine increased, Blood test abnormal, COVID-19
Clinical narrative: Patient is a 68 y.o. female admitted to the hospital on 10/19/2022 for with nausea, poor p.o. intake and worsening renal function on blood work.   Discharge Diagnosis and Associated Hospital Course   AKI on CKD3b None anion gap metabolic acidosis Kidney transplant Secondary to ongoing GI losses and diarrhea known h/o ESRD s/p renal transplant 1.5yrs ago. Follows with Dr.  -Baseline SCR appears to be around 1.2 -Tacrolimus level stable -UA negative renal US nonacute -stool PCR negative, COVID-19 positive.   -Continue Myfortic 540 mg q12h, Bactrim DS daily. Hold Chlorthalidone, tacrolimus. -Dexamethasone for Immunosuppression while off tacrolimus now restarting tacrolimus so stopped dexamethasone -IV fluid stopped as diarrhea better and eating better    Infectious diarrhea-improving COVID-19 infection Hypokalemia Ongoing diarrhea likely secondary to COVID-19 infection as well as Myfortic. -Maintained on room air, no indication for dexamethasone or remdesivir at this time. -S/p monoclonal antibody treatment 10/21 -Continue aggressive potassium replacement -nursing state diarrhea significantly improve,   Acute on chronic anemia Likely due to ongoing infection, AKI.  No blood loss noted. -Chronic component due to iron deficiency, recently started on iron. -Hgb around 8 on admission.  Hgb 6.3 on 10/21.  S/p 1 unit PRBC -Continue transfusion for Hgb <7 today 8   NIDDM2 with ckd3b -A1c 7.0% on 1/22/22. BG at goal.  Appears to be diet controlled -Continue sensitive corrective scale while inpatient. HTN Known history. Patient reports BP low normal with HR ~50 at home recently; she holds Procardia and Coreg for SBP<150. -Hypertensive on admission. -Continue home Procardia XL 60 mg q12h, Coreg 12.5 mg q12h. Hold home Chlorthalidone 25 mg qhs due to AKI.   HLD: Continue statin. Resume home Crestor 20 mg qhs on discharge. GERD: Continue home Pepcid. COPD: Not in exacerbation. Continue home Breo Ellipta.  OSA:Continue BiPAP while inpatient. Major recurrentDepression: Continue home Zoloft 50 mg qhs.  RLS: Continue home Requip 0.5 mg qhs.  Gout: Continue home Allopurinol 100 mg qhs.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Diarrhoea infectious, Drug level, Electrolyte substitution therapy, Haemoglobin decreased
Clinical narrative: Patient is a 68 y.o. female admitted to the hospital on 10/19/2022 for with nausea, poor p.o. intake and worsening renal function on blood work.   Discharge Diagnosis and Associated Hospital Course   AKI on CKD3b None anion gap metabolic acidosis Kidney transplant Secondary to ongoing GI losses and diarrhea known h/o ESRD s/p renal transplant 1.5yrs ago. Follows with Dr.  -Baseline SCR appears to be around 1.2 -Tacrolimus level stable -UA negative renal US nonacute -stool PCR negative, COVID-19 positive.   -Continue Myfortic 540 mg q12h, Bactrim DS daily. Hold Chlorthalidone, tacrolimus. -Dexamethasone for Immunosuppression while off tacrolimus now restarting tacrolimus so stopped dexamethasone -IV fluid stopped as diarrhea better and eating better    Infectious diarrhea-improving COVID-19 infection Hypokalemia Ongoing diarrhea likely secondary to COVID-19 infection as well as Myfortic. -Maintained on room air, no indication for dexamethasone or remdesivir at this time. -S/p monoclonal antibody treatment 10/21 -Continue aggressive potassium replacement -nursing state diarrhea significantly improve,   Acute on chronic anemia Likely due to ongoing infection, AKI.  No blood loss noted. -Chronic component due to iron deficiency, recently started on iron. -Hgb around 8 on admission.  Hgb 6.3 on 10/21.  S/p 1 unit PRBC -Continue transfusion for Hgb <7 today 8   NIDDM2 with ckd3b -A1c 7.0% on 1/22/22. BG at goal.  Appears to be diet controlled -Continue sensitive corrective scale while inpatient. HTN Known history. Patient reports BP low normal with HR ~50 at home recently; she holds Procardia and Coreg for SBP<150. -Hypertensive on admission. -Continue home Procardia XL 60 mg q12h, Coreg 12.5 mg q12h. Hold home Chlorthalidone 25 mg qhs due to AKI.   HLD: Continue statin. Resume home Crestor 20 mg qhs on discharge. GERD: Continue home Pepcid. COPD: Not in exacerbation. Continue home Breo Ellipta.  OSA:Continue BiPAP while inpatient. Major recurrentDepression: Continue home Zoloft 50 mg qhs.  RLS: Continue home Requip 0.5 mg qhs.  Gout: Continue home Allopurinol 100 mg qhs.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Hypertension, Hypokalaemia, Hypophagia, Immunosuppression, Iron deficiency anaemia
Clinical narrative: Patient is a 68 y.o. female admitted to the hospital on 10/19/2022 for with nausea, poor p.o. intake and worsening renal function on blood work.   Discharge Diagnosis and Associated Hospital Course   AKI on CKD3b None anion gap metabolic acidosis Kidney transplant Secondary to ongoing GI losses and diarrhea known h/o ESRD s/p renal transplant 1.5yrs ago. Follows with Dr.  -Baseline SCR appears to be around 1.2 -Tacrolimus level stable -UA negative renal US nonacute -stool PCR negative, COVID-19 positive.   -Continue Myfortic 540 mg q12h, Bactrim DS daily. Hold Chlorthalidone, tacrolimus. -Dexamethasone for Immunosuppression while off tacrolimus now restarting tacrolimus so stopped dexamethasone -IV fluid stopped as diarrhea better and eating better    Infectious diarrhea-improving COVID-19 infection Hypokalemia Ongoing diarrhea likely secondary to COVID-19 infection as well as Myfortic. -Maintained on room air, no indication for dexamethasone or remdesivir at this time. -S/p monoclonal antibody treatment 10/21 -Continue aggressive potassium replacement -nursing state diarrhea significantly improve,   Acute on chronic anemia Likely due to ongoing infection, AKI.  No blood loss noted. -Chronic component due to iron deficiency, recently started on iron. -Hgb around 8 on admission.  Hgb 6.3 on 10/21.  S/p 1 unit PRBC -Continue transfusion for Hgb <7 today 8   NIDDM2 with ckd3b -A1c 7.0% on 1/22/22. BG at goal.  Appears to be diet controlled -Continue sensitive corrective scale while inpatient. HTN Known history. Patient reports BP low normal with HR ~50 at home recently; she holds Procardia and Coreg for SBP<150. -Hypertensive on admission. -Continue home Procardia XL 60 mg q12h, Coreg 12.5 mg q12h. Hold home Chlorthalidone 25 mg qhs due to AKI.   HLD: Continue statin. Resume home Crestor 20 mg qhs on discharge. GERD: Continue home Pepcid. COPD: Not in exacerbation. Continue home Breo Ellipta.  OSA:Continue BiPAP while inpatient. Major recurrentDepression: Continue home Zoloft 50 mg qhs.  RLS: Continue home Requip 0.5 mg qhs.  Gout: Continue home Allopurinol 100 mg qhs.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Mineral supplementation, Nausea, Positive airway pressure therapy, Red blood cell transfusion, Renal impairment
Clinical narrative: Patient is a 68 y.o. female admitted to the hospital on 10/19/2022 for with nausea, poor p.o. intake and worsening renal function on blood work.   Discharge Diagnosis and Associated Hospital Course   AKI on CKD3b None anion gap metabolic acidosis Kidney transplant Secondary to ongoing GI losses and diarrhea known h/o ESRD s/p renal transplant 1.5yrs ago. Follows with Dr.  -Baseline SCR appears to be around 1.2 -Tacrolimus level stable -UA negative renal US nonacute -stool PCR negative, COVID-19 positive.   -Continue Myfortic 540 mg q12h, Bactrim DS daily. Hold Chlorthalidone, tacrolimus. -Dexamethasone for Immunosuppression while off tacrolimus now restarting tacrolimus so stopped dexamethasone -IV fluid stopped as diarrhea better and eating better    Infectious diarrhea-improving COVID-19 infection Hypokalemia Ongoing diarrhea likely secondary to COVID-19 infection as well as Myfortic. -Maintained on room air, no indication for dexamethasone or remdesivir at this time. -S/p monoclonal antibody treatment 10/21 -Continue aggressive potassium replacement -nursing state diarrhea significantly improve,   Acute on chronic anemia Likely due to ongoing infection, AKI.  No blood loss noted. -Chronic component due to iron deficiency, recently started on iron. -Hgb around 8 on admission.  Hgb 6.3 on 10/21.  S/p 1 unit PRBC -Continue transfusion for Hgb <7 today 8   NIDDM2 with ckd3b -A1c 7.0% on 1/22/22. BG at goal.  Appears to be diet controlled -Continue sensitive corrective scale while inpatient. HTN Known history. Patient reports BP low normal with HR ~50 at home recently; she holds Procardia and Coreg for SBP<150. -Hypertensive on admission. -Continue home Procardia XL 60 mg q12h, Coreg 12.5 mg q12h. Hold home Chlorthalidone 25 mg qhs due to AKI.   HLD: Continue statin. Resume home Crestor 20 mg qhs on discharge. GERD: Continue home Pepcid. COPD: Not in exacerbation. Continue home Breo Ellipta.  OSA:Continue BiPAP while inpatient. Major recurrentDepression: Continue home Zoloft 50 mg qhs.  RLS: Continue home Requip 0.5 mg qhs.  Gout: Continue home Allopurinol 100 mg qhs.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Stool analysis normal, Ultrasound kidney, Urine analysis normal
Clinical narrative: Patient is a 68 y.o. female admitted to the hospital on 10/19/2022 for with nausea, poor p.o. intake and worsening renal function on blood work.   Discharge Diagnosis and Associated Hospital Course   AKI on CKD3b None anion gap metabolic acidosis Kidney transplant Secondary to ongoing GI losses and diarrhea known h/o ESRD s/p renal transplant 1.5yrs ago. Follows with Dr.  -Baseline SCR appears to be around 1.2 -Tacrolimus level stable -UA negative renal US nonacute -stool PCR negative, COVID-19 positive.   -Continue Myfortic 540 mg q12h, Bactrim DS daily. Hold Chlorthalidone, tacrolimus. -Dexamethasone for Immunosuppression while off tacrolimus now restarting tacrolimus so stopped dexamethasone -IV fluid stopped as diarrhea better and eating better    Infectious diarrhea-improving COVID-19 infection Hypokalemia Ongoing diarrhea likely secondary to COVID-19 infection as well as Myfortic. -Maintained on room air, no indication for dexamethasone or remdesivir at this time. -S/p monoclonal antibody treatment 10/21 -Continue aggressive potassium replacement -nursing state diarrhea significantly improve,   Acute on chronic anemia Likely due to ongoing infection, AKI.  No blood loss noted. -Chronic component due to iron deficiency, recently started on iron. -Hgb around 8 on admission.  Hgb 6.3 on 10/21.  S/p 1 unit PRBC -Continue transfusion for Hgb <7 today 8   NIDDM2 with ckd3b -A1c 7.0% on 1/22/22. BG at goal.  Appears to be diet controlled -Continue sensitive corrective scale while inpatient. HTN Known history. Patient reports BP low normal with HR ~50 at home recently; she holds Procardia and Coreg for SBP<150. -Hypertensive on admission. -Continue home Procardia XL 60 mg q12h, Coreg 12.5 mg q12h. Hold home Chlorthalidone 25 mg qhs due to AKI.   HLD: Continue statin. Resume home Crestor 20 mg qhs on discharge. GERD: Continue home Pepcid. COPD: Not in exacerbation. Continue home Breo Ellipta.  OSA:Continue BiPAP while inpatient. Major recurrentDepression: Continue home Zoloft 50 mg qhs.  RLS: Continue home Requip 0.5 mg qhs.  Gout: Continue home Allopurinol 100 mg qhs.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac stress test, Computerised tomogram coronary artery, Echocardiogram, Electrocardiogram, Full blood count
Clinical narrative: Myocarditis
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Myocarditis
Clinical narrative: Myocarditis
Age: 29.0
Sex: F
Vaccine: COVID19-2
Symptoms: Urticaria
Clinical narrative: Hives all over body. Taking OTC antihistamine
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Hypoaesthesia, Injection site pain, Pain in extremity
Clinical narrative: Moderate pain in upper left arm at injection site Feeling of fatigue in the left arm Moderate pain in upper right arm Numbness in left forearm and hand
Age: 25.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: Fatigue, Pyrexia, Tremor
Clinical narrative: Approx 11hrs post-injection felt fatigued. At 12hrs post-injection, felt feverish and severe muscle tremors. Symptoms mirrored covid infection from two months prior, although these tremors were significantly more severe. Fever intensified and continued throughout the night, and had broken sometime before waking.
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Asthenia, Atrial fibrillation, Benign prostatic hyperplasia, COVID-19
Clinical narrative: The patient is a 92 y.o. male with history of BPH, hypertension, squamous cell carcinoma and dementia presented with generalized weakness and chills due to COVID 19 infection, acute hypoxic respiratory failure and in A fib with RVR.  He was followed by pulmonary, cardiology and palliative team. While his management was in progress, patient expired on 10/17/22 at 1335.    Discharge Diagnoses:   Acute respiratory failure with hypoxia. Sepsis due to covid-19 infection, POA Acute CHF exacerbation, systolic, uncompensated Elevated troponin without chest pain. A fib with RVR Hypokalemia Steroid induced hyperglycemia Benign essential hypertension BPH Severe malnutrition, POA
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac failure congestive, Chills, Condition aggravated, Death, Essential hypertension
Clinical narrative: The patient is a 92 y.o. male with history of BPH, hypertension, squamous cell carcinoma and dementia presented with generalized weakness and chills due to COVID 19 infection, acute hypoxic respiratory failure and in A fib with RVR.  He was followed by pulmonary, cardiology and palliative team. While his management was in progress, patient expired on 10/17/22 at 1335.    Discharge Diagnoses:   Acute respiratory failure with hypoxia. Sepsis due to covid-19 infection, POA Acute CHF exacerbation, systolic, uncompensated Elevated troponin without chest pain. A fib with RVR Hypokalemia Steroid induced hyperglycemia Benign essential hypertension BPH Severe malnutrition, POA
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: Hyperglycaemia, Hypokalaemia, Malnutrition, Sepsis, Troponin increased
Clinical narrative: The patient is a 92 y.o. male with history of BPH, hypertension, squamous cell carcinoma and dementia presented with generalized weakness and chills due to COVID 19 infection, acute hypoxic respiratory failure and in A fib with RVR.  He was followed by pulmonary, cardiology and palliative team. While his management was in progress, patient expired on 10/17/22 at 1335.    Discharge Diagnoses:   Acute respiratory failure with hypoxia. Sepsis due to covid-19 infection, POA Acute CHF exacerbation, systolic, uncompensated Elevated troponin without chest pain. A fib with RVR Hypokalemia Steroid induced hyperglycemia Benign essential hypertension BPH Severe malnutrition, POA
Age: 27.0
Sex: F
Vaccine: COVID19-2
Symptoms: Urticaria
Clinical narrative: Delayed urticaria- began 3 weeks after vaccine, still ongoing at the time of this report (6 weeks)
Age: 36.0
Sex: F
Vaccine: COVID19-2
Symptoms: Headache, Injection site erythema, Injection site pruritus
Clinical narrative: Very itchy red spot by injection site that grew over the course of 24 hours. Headache that didn?t go away with Tylenol or aspirin. Injection spot was just below the site of the needle.
Age: 68.0
Sex: F
Vaccine: PNC20
Symptoms: Hypersensitivity, Injection site erythema, Injection site rash, Injection site swelling
Clinical narrative: patient developed allergy days after vaccination, area of injection Red, swollen Rash began small enlarged to tricep area
Age: 21.0
Sex: F
Vaccine: COVID19-2, FLU4, COVID19-2
Symptoms: Dyspnoea, Pain in extremity
Clinical narrative: pt complained of arm pin and shortness of breath
Age: 51.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Abdominal pain, Autonomic nervous system imbalance, Balance disorder, Barium swallow, Blood test
Clinical narrative: Symptoms started on the evening of the injection. First reaction was fever of 105.8 degrees (f),  over the next few weeks developed tachycardia, shortness of breath, fatigue, and dizziness. This progressed to near syncope and syncope, nausea, vomiting, migraines and increased fatigue . Over the next few months developed/ was diagnosed with: vasovagal syndrome, dysautonomic orthostatic hypotension syndrome, gastroparesis, weight loss, Dysphagia, swallowing difficulties, change in voice,  tinnitus, vocal cord dysfunction syndrome, dysautonomia, paresthesia to hands and feet, pain, numbness and tingling to hands and feet, abdominal pain, balance disturbance, gait instability, weakness to extremities, vision disturbances, blurred vision and double vision, difficulties with visual tracking, motility issues , sleep disturbance and internal tremors
Age: 51.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Cardiac stress test, Computerised tomogram, Diplopia, Dizziness, Dysphagia
Clinical narrative: Symptoms started on the evening of the injection. First reaction was fever of 105.8 degrees (f),  over the next few weeks developed tachycardia, shortness of breath, fatigue, and dizziness. This progressed to near syncope and syncope, nausea, vomiting, migraines and increased fatigue . Over the next few months developed/ was diagnosed with: vasovagal syndrome, dysautonomic orthostatic hypotension syndrome, gastroparesis, weight loss, Dysphagia, swallowing difficulties, change in voice,  tinnitus, vocal cord dysfunction syndrome, dysautonomia, paresthesia to hands and feet, pain, numbness and tingling to hands and feet, abdominal pain, balance disturbance, gait instability, weakness to extremities, vision disturbances, blurred vision and double vision, difficulties with visual tracking, motility issues , sleep disturbance and internal tremors
Age: 51.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Dysphonia, Dyspnoea, Echocardiogram, Electrocardiogram ambulatory, Endoscopy
Clinical narrative: Symptoms started on the evening of the injection. First reaction was fever of 105.8 degrees (f),  over the next few weeks developed tachycardia, shortness of breath, fatigue, and dizziness. This progressed to near syncope and syncope, nausea, vomiting, migraines and increased fatigue . Over the next few months developed/ was diagnosed with: vasovagal syndrome, dysautonomic orthostatic hypotension syndrome, gastroparesis, weight loss, Dysphagia, swallowing difficulties, change in voice,  tinnitus, vocal cord dysfunction syndrome, dysautonomia, paresthesia to hands and feet, pain, numbness and tingling to hands and feet, abdominal pain, balance disturbance, gait instability, weakness to extremities, vision disturbances, blurred vision and double vision, difficulties with visual tracking, motility issues , sleep disturbance and internal tremors
Age: 51.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Fatigue, Gait disturbance, Gastric emptying study, Hypoaesthesia, Impaired gastric emptying
Clinical narrative: Symptoms started on the evening of the injection. First reaction was fever of 105.8 degrees (f),  over the next few weeks developed tachycardia, shortness of breath, fatigue, and dizziness. This progressed to near syncope and syncope, nausea, vomiting, migraines and increased fatigue . Over the next few months developed/ was diagnosed with: vasovagal syndrome, dysautonomic orthostatic hypotension syndrome, gastroparesis, weight loss, Dysphagia, swallowing difficulties, change in voice,  tinnitus, vocal cord dysfunction syndrome, dysautonomia, paresthesia to hands and feet, pain, numbness and tingling to hands and feet, abdominal pain, balance disturbance, gait instability, weakness to extremities, vision disturbances, blurred vision and double vision, difficulties with visual tracking, motility issues , sleep disturbance and internal tremors
Age: 51.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Magnetic resonance imaging, Migraine, Muscular weakness, Nausea, Orthostatic hypotension
Clinical narrative: Symptoms started on the evening of the injection. First reaction was fever of 105.8 degrees (f),  over the next few weeks developed tachycardia, shortness of breath, fatigue, and dizziness. This progressed to near syncope and syncope, nausea, vomiting, migraines and increased fatigue . Over the next few months developed/ was diagnosed with: vasovagal syndrome, dysautonomic orthostatic hypotension syndrome, gastroparesis, weight loss, Dysphagia, swallowing difficulties, change in voice,  tinnitus, vocal cord dysfunction syndrome, dysautonomia, paresthesia to hands and feet, pain, numbness and tingling to hands and feet, abdominal pain, balance disturbance, gait instability, weakness to extremities, vision disturbances, blurred vision and double vision, difficulties with visual tracking, motility issues , sleep disturbance and internal tremors
Age: 51.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Pain, Paraesthesia, Presyncope, Pyrexia, Sleep disorder
Clinical narrative: Symptoms started on the evening of the injection. First reaction was fever of 105.8 degrees (f),  over the next few weeks developed tachycardia, shortness of breath, fatigue, and dizziness. This progressed to near syncope and syncope, nausea, vomiting, migraines and increased fatigue . Over the next few months developed/ was diagnosed with: vasovagal syndrome, dysautonomic orthostatic hypotension syndrome, gastroparesis, weight loss, Dysphagia, swallowing difficulties, change in voice,  tinnitus, vocal cord dysfunction syndrome, dysautonomia, paresthesia to hands and feet, pain, numbness and tingling to hands and feet, abdominal pain, balance disturbance, gait instability, weakness to extremities, vision disturbances, blurred vision and double vision, difficulties with visual tracking, motility issues , sleep disturbance and internal tremors
Age: 51.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Swallow study, Syncope, Tachycardia, Tilt table test, Tinnitus
Clinical narrative: Symptoms started on the evening of the injection. First reaction was fever of 105.8 degrees (f),  over the next few weeks developed tachycardia, shortness of breath, fatigue, and dizziness. This progressed to near syncope and syncope, nausea, vomiting, migraines and increased fatigue . Over the next few months developed/ was diagnosed with: vasovagal syndrome, dysautonomic orthostatic hypotension syndrome, gastroparesis, weight loss, Dysphagia, swallowing difficulties, change in voice,  tinnitus, vocal cord dysfunction syndrome, dysautonomia, paresthesia to hands and feet, pain, numbness and tingling to hands and feet, abdominal pain, balance disturbance, gait instability, weakness to extremities, vision disturbances, blurred vision and double vision, difficulties with visual tracking, motility issues , sleep disturbance and internal tremors
Age: 51.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Tremor, Vision blurred, Visual impairment, Vocal cord dysfunction, Vomiting
Clinical narrative: Symptoms started on the evening of the injection. First reaction was fever of 105.8 degrees (f),  over the next few weeks developed tachycardia, shortness of breath, fatigue, and dizziness. This progressed to near syncope and syncope, nausea, vomiting, migraines and increased fatigue . Over the next few months developed/ was diagnosed with: vasovagal syndrome, dysautonomic orthostatic hypotension syndrome, gastroparesis, weight loss, Dysphagia, swallowing difficulties, change in voice,  tinnitus, vocal cord dysfunction syndrome, dysautonomia, paresthesia to hands and feet, pain, numbness and tingling to hands and feet, abdominal pain, balance disturbance, gait instability, weakness to extremities, vision disturbances, blurred vision and double vision, difficulties with visual tracking, motility issues , sleep disturbance and internal tremors
Age: 51.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Weight decreased
Clinical narrative: Symptoms started on the evening of the injection. First reaction was fever of 105.8 degrees (f),  over the next few weeks developed tachycardia, shortness of breath, fatigue, and dizziness. This progressed to near syncope and syncope, nausea, vomiting, migraines and increased fatigue . Over the next few months developed/ was diagnosed with: vasovagal syndrome, dysautonomic orthostatic hypotension syndrome, gastroparesis, weight loss, Dysphagia, swallowing difficulties, change in voice,  tinnitus, vocal cord dysfunction syndrome, dysautonomia, paresthesia to hands and feet, pain, numbness and tingling to hands and feet, abdominal pain, balance disturbance, gait instability, weakness to extremities, vision disturbances, blurred vision and double vision, difficulties with visual tracking, motility issues , sleep disturbance and internal tremors
Age: 10.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Error: Wrong Vaccine Formulation (ex. Prevnar 13 v. Prevnar 23)-
Age: 18.0
Sex: F
Vaccine: FLU4
Symptoms: Eye movement disorder, Fall, Feeling abnormal, Head injury, Immediate post-injection reaction
Clinical narrative: Systemic: Fainting / Unresponsive-Medium, Systemic: Vomiting-Mild, Additional Details: Immediately after administration the patient indicated they were not feeling good. Her mother was holding her hand in support and noticed she was fainting. She alterted the pharmacist as she had turned around to get the next vaccine ready (a COVID booster). Patient fell back from the chair to the ground, hit her head on the privacy screen. Her eyes were rolled back and she was not breathing. Pharmacist immediately called EMS. Her mom helped the patient back up and paramedics checked on her.
Age: 18.0
Sex: F
Vaccine: FLU4
Symptoms: Respiratory arrest, Syncope, Unresponsive to stimuli, Vomiting
Clinical narrative: Systemic: Fainting / Unresponsive-Medium, Systemic: Vomiting-Mild, Additional Details: Immediately after administration the patient indicated they were not feeling good. Her mother was holding her hand in support and noticed she was fainting. She alterted the pharmacist as she had turned around to get the next vaccine ready (a COVID booster). Patient fell back from the chair to the ground, hit her head on the privacy screen. Her eyes were rolled back and she was not breathing. Pharmacist immediately called EMS. Her mom helped the patient back up and paramedics checked on her.
Age: 16.0
Sex: U
Vaccine: FLUC4
Symptoms: Bladder dysfunction, Confusional state, Dizziness, Syncope, Unresponsive to stimuli
Clinical narrative: Systemic: Confusion-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Medium, Additional Details: pt lost bladder control after faintness. mom is aware of this condition and states "this happens everytime she get a shot".
Age: 56.0
Sex: F
Vaccine: COVID19-2
Symptoms: Injection site bruising, Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: Site: Bruising at Injection Site-Mild, Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Medium, Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Additional Details: Patient described upper part of arm as being swollen, red, and hot with a goose-egg like area that lasted for 5 days. Red and purple circular bruise keeps reappearing. She has faint red rash/ discoloration still (2 months later)
Age: 56.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pruritus, Rash
Clinical narrative: Site: Bruising at Injection Site-Mild, Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Medium, Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Additional Details: Patient described upper part of arm as being swollen, red, and hot with a goose-egg like area that lasted for 5 days. Red and purple circular bruise keeps reappearing. She has faint red rash/ discoloration still (2 months later)
Age: 56.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling, Injection site warmth
Clinical narrative: Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Additional Details: Patient received flulaval on Monday, November 7 at a flu clinic at her place of employment.  She reported to the Employers nurse on site that she was having a local injection site reaction to the shot. Nurse reported red, tender, sore, hot, horizonatal 1" by 3" raised red area on deltoid area of arm, with some localized itch.  The nurse on site gave her an ice pack for about 20 minutes, ibuprofen, benadryl, and a topical pain/hydrocortisone cream.
Age: 12.0
Sex: F
Vaccine: COVID19-2
Symptoms: Chills, Insomnia, Oesophageal achalasia, Pyrexia, Vomiting
Clinical narrative: Vomiting, 101.3 fever, aches, chills, sleeplessness
Age: 66.0
Sex: F
Vaccine: PNC20
Symptoms: Injection site bruising, Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: Site: Bruising at Injection Site-Medium, Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium
Age: 66.0
Sex: F
Vaccine: PNC20
Symptoms: Rash
Clinical narrative: Site: Bruising at Injection Site-Medium, Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Error: Wrong Vaccine Formulation (ex. Prevnar 13 v. Prevnar 23)-
Age: 39.0
Sex: F
Vaccine: COVID19-2
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Error: Dose in Series Given Too Early-
Age: 79.0
Sex: F
Vaccine: FLUA4
Symptoms: Pruritus, Rash
Clinical narrative: Systemic: Allergic: Itch Generalized-Medium, Systemic: Allergic: Rash Generalized-Mild
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Wrong product administered
Clinical narrative: Error: Wrong Vaccine/Product Administered-
Age: 87.0
Sex: F
Vaccine: COVID19-2
Symptoms: Injection site erythema
Clinical narrative: Site: Redness at Injection Site-Medium, Additional Details: Patient got benadryl and will treat herself.  She said it was mild and will contact us if it becomes more severe.
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Error: Wrong Vaccine Formulation (ex. Prevnar 13 v. Prevnar 23)-
Age: 38.0
Sex: M
Vaccine: COVID19-2
Symptoms: Syncope, Unresponsive to stimuli
Clinical narrative: Systemic: Fainting / Unresponsive-Medium
Age: 69.0
Sex: F
Vaccine: FLU4
Symptoms: Contusion, Injection site bruising, Injection site erythema, Injection site swelling, Peripheral swelling
Clinical narrative: Site: Bruising at Injection Site-Mild, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Additional Details: Patient came to the pharmacy 11/7/2022, and explained to me that intern advised pt. to roll up her sleeve to administer her flu shot. The next day her arm was swollen, and had significant bruising from a photo she brought to my attention. I told her a mild to moderate rash is rare but not uncommon with any vaccine, and it may have been due to either the administration of the flu shot or just by chance. She said she'd contact me later this week if any concerns.
Age: 77.0
Sex: F
Vaccine: COVID19-2
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: Site: Itching at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild
Age: 65.0
Sex: M
Vaccine: FLU4
Symptoms: Asthenia, Chills, Dizziness, Fatigue, Headache
Clinical narrative: Site: Pain at Injection Site-Severe, Systemic: Body Aches Generalized-Medium, Systemic: Chills-Severe, Systemic: Dizziness / Lightheadness-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: Headache-Severe, Systemic: Nausea-Severe, Systemic: Weakness-Severe
Age: 65.0
Sex: M
Vaccine: FLU4
Symptoms: Injection site pain, Lethargy, Nausea, Pain
Clinical narrative: Site: Pain at Injection Site-Severe, Systemic: Body Aches Generalized-Medium, Systemic: Chills-Severe, Systemic: Dizziness / Lightheadness-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: Headache-Severe, Systemic: Nausea-Severe, Systemic: Weakness-Severe
Age: 10.0
Sex: M
Vaccine: COVID19-2
Symptoms: Wrong product administered
Clinical narrative: Error: Wrong Vaccine Formulation (ex. Prevnar 13 v. Prevnar 23)-
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Chest discomfort, Chest pain, Electrocardiogram ambulatory, Extrasystoles, Heart rate irregular
Clinical narrative: Heart Palpitations and chest tightness.  It was a dull ache it felt like someone was "squeezing my heart gently".  Heart felt like it was skipping a bit or a heavy beat once a minute felt mostly at night lying down.   I have been seeing articles lately about myocarditis with Moderna vaccine and felt like it was my duty to report this.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Palpitations
Clinical narrative: Heart Palpitations and chest tightness.  It was a dull ache it felt like someone was "squeezing my heart gently".  Heart felt like it was skipping a bit or a heavy beat once a minute felt mostly at night lying down.   I have been seeing articles lately about myocarditis with Moderna vaccine and felt like it was my duty to report this.
Age: 13.0
Sex: F
Vaccine: COVID19-2
Symptoms: Dyspnoea
Clinical narrative: Systemic: Allergic: Difficulty Breathing-Severe
Age: 59.0
Sex: F
Vaccine: PNC20
Symptoms: Dyspnoea
Clinical narrative: Systemic: Allergic: Difficulty Breathing-Medium, Additional Details: pt stated couldn't breath, and took benadryl. Took blood pressure, pulse and O2 sat all were within normal limits.
Age: 44.0
Sex: F
Vaccine: COVID19-2
Symptoms: Deafness unilateral, Lymphadenopathy
Clinical narrative: I received my Moderna updated Covid booster at approximately 3:30pm on Friday November 11th, 2022. I woke up on Saturday the 12th and could not hear out of my left ear (the same side I received my vaccine). It lasted all day until I woke up Sunday morning (the 13th) and could hear normally. I did not have any congestion or cold symptoms, I just couldn?t hear out if that ear. I also have very swollen lymph nodes in my left armpit and left collarbone area.  I will mention that I have had the swollen lymph nodes before but never the hearing loss. I would also like to mention that this was my first Moderna Covid vaccine. All my other doses were Pfizer.
Age: 78.0
Sex: F
Vaccine: COVID19-2
Symptoms: Unresponsive to stimuli
Clinical narrative: Unresponsive on 11/12/2022
Age: 69.0
Sex: M
Vaccine: COVID19-2
Symptoms: Balance disorder, Cardiac flutter, Dizziness
Clinical narrative: Initially heart flutter, followed by very bad dizziness, and balance issues.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Abnormal menstrual clots, Heavy menstrual bleeding
Clinical narrative: After the vaccine, my period got heavier and come with larger blood clot.   As today, my periods are still very heavy.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Inflammation, Myalgia
Clinical narrative: The most incredibly intense soreness and pain in every muscle for months and months as well as general inflammation.   Now, over a year later the intensity has subsided but still experience sore muscles everywhere for every activity and inflammation is still a problem
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Administered Pfizer monovalent product instead of bivalent product
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, Gait inability, Mobility decreased, Pain in extremity, Weight bearing difficulty
Clinical narrative: Starting in July, middle of normal 4 mile run, pain in left thigh, could not walk.  August while hiking in mountains, 3/4 finished could not walk pain left thigh.  Later reduced and could walk run.  Sept. pain returned could not bend left eg or put weight on it.  Doing P.T. and pain reducing
Age: 42.0
Sex: F
Vaccine: FLUR4
Symptoms: Chills, Headache, Pain, Pyrexia, Vomiting
Clinical narrative: High fever, vomiting multiple times, chills, body aches, headache
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Administered Pfizer monovalent product instead of bivalent product
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Administered Pfizer monovalent product instead of bivalent product
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Administered Pfizer monovalent product instead of bivalent product
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Administered Pfizer monovalent product instead of bivalent product
Age: 62.0
Sex: F
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: TEMP EXCURSION- VACCINE AT ROOM TEMP (68*) FOR >12 HOURS. PT HAD NO SIDE EFFECTS TO REPORT
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Administered Pfizer monovalent product instead of bivalent product
Age: 70.0
Sex: F
Vaccine: COVID19-2
Symptoms: Fatigue, Tremor
Clinical narrative: My wife has had 5 Covid shots. The first three were Pfizer with no adverse reaction. The fourth was Moderna with fatigue that lasted a day as the reaction.  The fifth shot, yesterday, was Pfizer. The adverse reaction was  sufficient to cause me to  now report it. My wife spent hours last night shaking uncontrollably. The shaking was quite scary since for the 50 years we?ve been married, she has never been sick. She remains at 9am exhausted from  the experience.
Age: 54.0
Sex: M
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: TEMP EXCURSION- VACCINE AT ROOM TEMP (68*) FOR >12 HOURS. PT HAD NO SIDE EFFECTS TO REPORT
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Administered Pfizer monovalent product instead of bivalent product
Age: 42.0
Sex: F
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: TEMP EXCURSION- ROOM TEMP (68*) FOR >12 HOURS. PT REPORTS NO ADVERSE EFFECTS
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Administered Pfizer monovalent product instead of bivalent product
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Administered Pfizer monovalent product instead of bivalent product
Age: 68.0
Sex: M
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: TEMP EXCURSION- ROOM TEMP (68*) FOR >12 HOURS. PT REPORTS NO ADVERSE EFFECTS
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Administered Pfizer monovalent product instead of bivalent product
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Administered Pfizer monovalent product instead of bivalent product
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Administered Pfizer monovalent product instead of bivalent product
Age: 58.0
Sex: M
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: TEMP EXCURSION- ROOM TEMP (68*) FOR >12 HOURS. PT REPORTS NO ADVERSE EFFECTS
Age: 49.0
Sex: M
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: TEMP EXCURSION- ROOM TEMP (68*) FOR >12 HOURS. PT REPORTS NO ADVERSE EFFECTS
Age: 42.0
Sex: F
Vaccine: COVID19-2
Symptoms: Eye pruritus, Headache, Injection site pain, Lacrimation increased, Myalgia
Clinical narrative: Initial symptoms: pain at injection site, muscle aches and headache 12 hours after vaccine. Took Advil and felt much better.   Periorbital Edema approximately 24 hours after vaccine administration? started in right eye and 5 hours later presented in both eyes. Initially no medicine taken? no itchy, pain or watery eyes  Went to sleep and woke up at 9am following day (11/13/22) both eye lids extremely swollen, watery and somewhat itchy.  Took 2 pills of Benadryl. Symptoms starting to subside.
Age: 42.0
Sex: F
Vaccine: COVID19-2
Symptoms: Periorbital oedema, Swelling of eyelid
Clinical narrative: Initial symptoms: pain at injection site, muscle aches and headache 12 hours after vaccine. Took Advil and felt much better.   Periorbital Edema approximately 24 hours after vaccine administration? started in right eye and 5 hours later presented in both eyes. Initially no medicine taken? no itchy, pain or watery eyes  Went to sleep and woke up at 9am following day (11/13/22) both eye lids extremely swollen, watery and somewhat itchy.  Took 2 pills of Benadryl. Symptoms starting to subside.
Age: 84.0
Sex: F
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: TEMP EXCURSION- ROOM TEMP (68*) FOR >12 HOURS. PT REPORTS NO SIDE EFFECTS
Age: 52.0
Sex: F
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: TEMP EXCURSION- ROOM TEMP (68*) FOR >12 HOURS. PT REPORTS NO SIDE EFFECTS
Age: 35.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Ageusia, Anosmia
Clinical narrative: Dulled/lost sense of taste and smell. Lasted at least a day. Symptoms noticed 11/12 1:30pm, were worst around 7:20pm (described as "5% taste"). Symptoms at 11/13 10:15am: taste and smell mostly back (described as "50 - 75% taste back"). Wrote and submitted this report at 10:45am.
Age: 62.0
Sex: M
Vaccine: COVID19-2
Symptoms: Influenza like illness, Injection site erythema, Injection site swelling, Musculoskeletal stiffness, Nasopharyngitis
Clinical narrative: Serious swelling and redness to left arm around injection area neck ache and stifness. flu like cold like symptoms no fever
Age: 62.0
Sex: M
Vaccine: COVID19-2
Symptoms: Neck pain
Clinical narrative: Serious swelling and redness to left arm around injection area neck ache and stifness. flu like cold like symptoms no fever